- Analytics & Modeling - Digital Twin / Simulation
- Process Manufacturing
- Digital Twin
GSK wanted to improve their vaccine manufacturing processes and see how they could effectively optimize the development process.
GlaxoSmithKline (GSK) is one of the world's largest research-based pharmaceutical companies that that discovers, develops, manufactures and markets human health products. It is an innovative company that produces branded products only, which it has developed itself.
GSK partnered with Siemens and Atos to create a digital twin of their factory process for creating a vaccine adjuvant, a molecule that helps spark a robust immune response.
The twin allows GSK to tweak, innovate, and simulate the entire process, unlocking hidden gains and fixing problems before they happen.
GSK plans to gradually implement digital twins into more and more processes, and eventually incorporate them into vaccine R&D, as well, where reduced need for real experimentation may make the process quicker, more cost effective, and sustainable.
Case Study missing?
Start adding your own!
Register with your work email and create a new case study profile for your business.